Data Analytics Company Informing Clinical Decisions in Molecular Medicine Scheduled to Present on December 3, 2013
San Francisco, Calif., Nov. 20, 2013 (GLOBE NEWSWIRE) — CollabRx, Inc. (CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, announces that Thomas R. Mika, Chief Executive Officer, will present at the LD MICRO Sixth Annual Conference at 11 a.m. (PST), Track 1, on December 3, 2013. The conference will be held December 3-5, 2013 at the Luxe Sunset Bel Air, 11461 Sunset Boulevard, Los Angeles, California. CollabRx management will be available during the day on December 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
CollabRx, Inc. (CLRX) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world’s knowledge on genomics-based medicine with specific insights from the nation’s top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com.
About LD MICRO
LD MICRO is a by-invitation only newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published an annual list of recommended stocks as well as comprehensive reports on select companies throughout the year. LD MICRO concentrates on finding, researching, and investing in companies that are overlooked by institutional investors. It is a non-registered investment advisor. To register, please call 408-457-1042 or e-mail firstname.lastname@example.org.
Investor Relations Contacts:
Thomas R. Mika, CEO
James Carbonara, Regional Vice President